Roth Capital Predicts Weaker Earnings for Journey Medical
Journey Medical Co. (NASDAQ:DERM – Free Report) – Research analysts at Roth Capital dropped their Q1 2025 earnings estimates for shares of Journey Medical in a research note issued to investors on Thursday, March 27th. Roth Capital analyst J. Wittes now forecasts that the company will earn ($0.19) per share for the quarter, down from […]
Journey Medical Co. (NASDAQ:DERM – Free Report) – Research analysts at Roth Capital dropped their Q1 2025 earnings estimates for shares of Journey Medical in a research note issued to investors on Thursday, March 27th. Roth Capital analyst J. Wittes now forecasts that the company will earn ($0.19) per share for the quarter, down from […]
